HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 80 filers reported holding HARVARD BIOSCIENCE INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $211,000 | +61.1% | 33,916 | +83.2% | 0.00% | – |
| Q4 2021 | $131,000 | -29.2% | 18,516 | -30.0% | 0.00% | – |
| Q3 2021 | $185,000 | -86.3% | 26,465 | -83.7% | 0.00% | -100.0% |
| Q2 2021 | $1,351,000 | +1610.1% | 162,134 | +1019.8% | 0.00% | – |
| Q1 2021 | $79,000 | +16.2% | 14,479 | -8.4% | 0.00% | – |
| Q4 2020 | $68,000 | +23.6% | 15,811 | +23.5% | 0.00% | – |
| Q1 2019 | $55,000 | -11.3% | 12,801 | -21.8% | 0.00% | – |
| Q3 2015 | $62,000 | -68.4% | 16,364 | -65.9% | 0.00% | – |
| Q3 2014 | $196,000 | -10.5% | 47,988 | -0.1% | 0.00% | – |
| Q2 2014 | $219,000 | -4.8% | 48,060 | -1.0% | 0.00% | -100.0% |
| Q1 2014 | $230,000 | -2.5% | 48,549 | -3.5% | 0.00% | 0.0% |
| Q4 2013 | $236,000 | +105.2% | 50,317 | +130.5% | 0.00% | – |
| Q3 2013 | $115,000 | +66.7% | 21,833 | +48.9% | 0.00% | – |
| Q2 2013 | $69,000 | – | 14,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |